• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by R1 RCM Inc.

    11/14/24 4:15:54 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary
    Get the next $RCM alert in real time by email
    8-K
    R1 RCM Inc. /DE false 0001910851 0001910851 2024-11-14 2024-11-14

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)

    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): November 14, 2024

     

     

    R1 RCM Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-41428   87-4340782

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    433 W. Ascension Way    
    Suite 200    
    Murray, Utah     84123
    (Address of Principal Executive Offices)     (Zip Code)

    Registrant’s telephone number, including area code: (312) 324-7820

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange

    on which registered

    Common stock, $0.01 par value per share   RCM   NASDAQ

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     


    Item 5.07 Submission of Matters to a Vote of Securities Holders.

    As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Project Raven Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub”), providing for, among other things and on the terms and subject to the conditions set forth therein, the merger of Merger Sub with and into the Company, with the Company continuing as the surviving corporation (the “Merger”), as described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on October 16, 2024, as amended (the “Definitive Proxy Statement”), and mailed to the Company’s stockholders on or about October 16, 2024.

    On November 14, 2024, the Company held a special meeting of stockholders virtually via live webcast (the “Special Meeting”) to vote on the proposals identified in the Definitive Proxy Statement.

    As of the close of business on October 11, 2024, the record date for the Special Meeting, there were 422,194,725 shares of common stock of the Company, par value $0.01 per share (the “Company Common Stock”), eligible to be voted at the Special Meeting. At the Special Meeting, 388,084,485 shares, or approximately 91.92% of all outstanding shares of Company Common Stock eligible to be voted at the Special Meeting, were present virtually or represented by proxy at the Special Meeting, constituting a quorum. Set forth below are the final voting results for the matters submitted to a vote of stockholders at the Special Meeting.

    Proposal No. 1 – The Merger Proposal.

    At the Special Meeting, the Company’s stockholders approved a proposal to approve and adopt the Merger Agreement and approve the transactions contemplated thereby. The votes were as follows:

     

    For

     

    Against

     

    Abstain

     

    Broker Non-Votes

    377,486,987   2,477,176   8,120,322   —

    Proposal No. 2 – The Merger-Related Compensation Proposal.

    At the Special Meeting, the Company’s stockholders approved, on an advisory and non-binding basis, a proposal to approve certain compensation arrangements for the Company’s named executive officers in connection with the Merger. The votes were as follows:

     

    For

     

    Against

     

    Abstain

     

    Broker Non-Votes

    364,416,611   15,044,874   8,623,000   —

     


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        R1 RCM INC.
    Date: November 14, 2024     By:  

    /s/ Jennifer Williams

        Name:   Jennifer Williams
        Title:   Chief Financial Officer
    Get the next $RCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RCM

    DatePrice TargetRatingAnalyst
    8/8/2024Overweight → Equal-Weight
    Morgan Stanley
    8/1/2024Overweight → Equal-Weight
    Stephens
    8/1/2024Outperform → Market Perform
    Leerink Partners
    8/1/2024Buy → Hold
    Jefferies
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    3/20/2024$16.00Neutral → Buy
    Citigroup
    2/26/2024$14.00Outperform
    Leerink Partners
    1/3/2024$14.00Overweight
    Barclays
    More analyst ratings

    $RCM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • TowerBrook and CD&R Complete Acquisition of R1 RCM

      MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w

      11/19/24 9:06:28 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/22/24 4:05:14 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:37:21 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:35:59 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • R1 RCM downgraded by Morgan Stanley

      Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight

      8/8/24 8:58:18 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Stephens

      Stephens downgraded R1 RCM from Overweight to Equal-Weight

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Leerink Partners

      Leerink Partners downgraded R1 RCM from Outperform to Market Perform

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Financials

    Live finance-specific insights

    See more
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM Reports Second Quarter 2024 Results

      MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte

      8/7/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

      MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

      8/1/24 7:30:34 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Leadership Updates

    Live Leadership Updates

    See more
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • James Hardie Industries Announces Global Leadership Appointment

      Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li

      8/16/23 9:50:00 PM ET
      $JHX
      $RCM
      Building Materials
      Industrials
      Other Consumer Services
      Consumer Discretionary
    • R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

      MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian

      8/12/21 8:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    SEC Filings

    See more
    • SEC Form POSASR filed by R1 RCM Inc.

      POSASR - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:26:18 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:18:28 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:17:27 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/22/24 4:06:56 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/19/24 4:36:38 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      8/5/24 7:31:56 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary